Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06359015 · ClinicalTrials.gov registry record · Phase 4
Metformin and Esomeprazole in Preterm Pre-eclampsia
A Phase 4 study, sponsored by Christiana Care Health Services.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT06359015 is a Phase 4 study that was terminated before completion, run by Christiana Care Health Services. The registered enrollment target is 4 participants.
The verdict
NCT06359015, a Phase 4 study, was terminated before completion, sponsored by Christiana Care Health Services.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand diagnosis and treatment of preterm preeclampsia. Currently, there are limited laboratory tests that can be used to diagnosis preeclampsia. Additionally, there are few treatments for this condition. This clinical trial will explore treatment options, Metformin and Esomeprazole, as well as serum markers that could improve the diagnosis and treatment of preterm preeclampsia.
Interventions
- DRUG Metformin
- DRUG Esomeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-02-11 |
| Est. Completion | 2025-05-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06359015
The ClinicalTrials.gov registry entry for NCT06359015 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT06359015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06359015 about?
NCT06359015 is a clinical study titled "Metformin and Esomeprazole in Preterm Pre-eclampsia". The purpose of this study is to better understand diagnosis and treatment of preterm preeclampsia. Currently, there are limited laboratory tests that can be used to diagnosis preeclampsia. Additionally, there are few treatments for this condition. This clinical trial will explore treatment options, ...
What is the current status of trial NCT06359015?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2021-02-11. Estimated completion is 2025-05-08.
What interventions are being tested in trial NCT06359015?
The interventions under investigation include: Metformin (DRUG), Esomeprazole (DRUG).
Who is sponsoring clinical trial NCT06359015?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.